The pathophysiological basis of acute-onchronic liver failure, Liver. 1 avr, vol.22, p.513, 2002. ,
Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria, Liver Transplantation, vol.228, issue.2, p.1639, 2000. ,
DOI : 10.1002/lt.500060218
Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems, Hepatology, vol.34, issue.2, p.25561, 2001. ,
DOI : 10.1053/jhep.2001.26522
Dialysis against a Recycled Albumin Solution Enables the Removal of Albumin-Bound Toxins, Artificial Organs, vol.14, issue.9, p.80913, 1993. ,
DOI : 10.1111/j.1525-1594.1993.tb00635.x
Coagulation abnormalities in the cirrhotic patient, Ann Hepatol. oct, vol.12, issue.5, p.71324, 2013. ,
Fibrinogen derivatives and platelet activation products in acute and chronic liver disease, Clinical Science, vol.68, issue.6, p.7017, 1985. ,
DOI : 10.1042/cs0680701
Thromboelastography to Monitor Clotting/Bleeding Complications in Patients Treated with the Molecular Adsorbent Recirculating System Crit Care Res Pract [Internet], First clinical experience with Molecular Adsorbent Recirculating System (MARS) in six patients with severe acute on chronic liver failure. Liver. 1 avr, p.5962, 2002. ,
Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications, Liver International, vol.3, issue.2, p.47584, 2007. ,
DOI : 10.1093/bja/69.3.307
A new simplified acute physiology score (saps ii) based on a european/north american multicenter study, JAMA. 22 déc, vol.270, issue.24, p.295763, 1993. ,
A model to predict survival in patients with end-stage liver disease, Hepatology. 1 févr, vol.33, issue.2, p.46470, 2001. ,
A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver, Int J Artif Organs. nov, vol.19, issue.11, p.67791, 1996. ,
Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: A meta-analysis, Liver Transplantation, vol.26, issue.9, p.1099106, 2004. ,
DOI : 10.1002/lt.20139
Artificial and bioartificial support systems for liver failure In: Cochrane Database of Systematic Reviews, Disponible sur, 2004. ,
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial, Liver Transpl. 1 mai, vol.6, issue.3, p.27786, 2000. ,
Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study, Hepatology. 1 oct, vol.36, issue.4, p.94958, 2002. ,
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis, Hepatology, vol.5, issue.6, p.185362, 2007. ,
DOI : 10.1002/hep.21930
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial, Hepatology, vol.50, issue.Suppl 3, p.115362, 2013. ,
DOI : 10.1002/hep.26185
Molecular Adsorbent Recycling System (MARS): Clinical Results of a New Membrane-Based Blood Purification System for Bioartificial Liver Support, Artificial Organs, vol.42, issue.2, p.31930, 1999. ,
DOI : 10.1006/abbi.1997.0258
Molecular Adsorbent Recirculating System as Artificial Support Therapy for Liver Failure, ASAIO Journal, vol.58, issue.1, p.519, 2012. ,
DOI : 10.1097/MAT.0b013e31823fd077
Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system*, Critical Care Medicine, vol.39, issue.2, p.2739, 2011. ,
DOI : 10.1097/CCM.0b013e3181fee8a4
The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure, Intensive Care Medicine, vol.23, issue.11, p.15449, 2005. ,
DOI : 10.1007/s00134-005-2786-y
Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system, Clinical Transplantation, vol.69, issue.4, p.36571, 2004. ,
DOI : 10.1046/j.1525-1594.1998.06162.x
Biocompatibility of modified polyethersulfone membranes by blending an amphiphilic triblock co-polymer of poly(vinyl pyrrolidone)?bpoly(methyl methacrylate)?b-poly(vinyl pyrrolidone), Acta Biomater. sept, vol.7, issue.9, p.337081, 2011. ,
Activation of Coagulation During Hemodialysis: Effect of Blood Lines Alone and Whole Extracorporeal Circuit, Artificial Organs, vol.19, issue.2, p.10610, 2006. ,
DOI : 10.1046/j.1523-1755.1999.00671.x
Plasma Cytokine Levels and Coagulation and Complement Activation During Use of the Extracorporeal Liver Assist Device in Acute Liver Failure, Artificial Organs, vol.17, issue.10, p.8548, 1998. ,
DOI : 10.1084/jem.185.9.1619
Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study, Critical Care, vol.10, issue.1, p.24, 2006. ,
DOI : 10.1186/cc3985
388 -Diminution du hépatique aiguë sévère traitée par le système MARS ®, 2009. ,
Continuous Venovenous Hemofiltration Without Anticoagulation, ASAIO Journal, vol.50, issue.1, p.7680, 1992. ,
DOI : 10.1097/01.MAT.0000104822.30759.A7
The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit, American Journal of Kidney Diseases, vol.30, issue.5, 1997. ,
DOI : 10.1016/S0272-6386(97)90538-2
The Molecular Adsorbent Recirculating System (MARS®) in the intensive care unit: a rescue therapy for patients with hepatic failure, Critical Care, vol.10, issue.1, p.118, 2006. ,
DOI : 10.1186/cc4825
Liver Transplantation Avoided in Patients With Fulminant Hepatic Failure Who Received Albumin Dialysis With the Molecular Adsorbent Recirculating System While on the Waiting List: Impact of the Duration of Therapy, Therapeutic Apheresis and Dialysis, vol.77, issue.3, p.54955, 2009. ,
DOI : 10.1111/j.1744-9987.2009.00708.x
Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System, Blood Purification, vol.21, issue.3, p.24452, 2003. ,
DOI : 10.1159/000070697
la membrane MARS FLUX, DIA MARS IE 250 (échangeur d'ions) et DIA MARS AC 250 (Charbon actif) en fin de traitement. Notez la différence de teintes des membranes témoins de l ,